ARCHIVES

House, Senate Must Resolve Major Differences In Authorization Bills

This article is from The Cancer Letter archive.

Vol. 06 No. 36 | September 12, 1980

Download PDF Visit The Full Archive

Related Articles

Oral UFT Equivalent To FULV In Stage II and III Colon Cancer

July 30, 2004

Guest Editorial: Even Slam-Dunk Applications Can Benefit From Public Scrutiny and Discussion at ODAC

August 10, 2012

Science Policy: Increased Cancer Death Rate For Atomic Vets Not Significant, OIM Says

October 29, 1999

Workshop concludes HPV Vaccines Would Be Valuable, Feasible

April 8, 1988

John Durant Names ASCO Executive NP; A New Position, New Voice In Washington

December 2, 1994

Pittsburgh Broadens Inquiry To Include Lawrence Wickerham

July 15, 1994